CIG
Cascade Investment Group’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.28M | Buy |
6,884
+25
| +0.4% | +$4.64K | 0.89% | 31 |
|
2025
Q1 | $1.44M | Sell |
6,859
-135
| -2% | -$28.3K | 1.11% | 25 |
|
2024
Q4 | $1.24M | Sell |
6,994
-170
| -2% | -$30.2K | 0.89% | 32 |
|
2024
Q3 | $1.41M | Buy |
7,164
+22
| +0.3% | +$4.34K | 1.04% | 24 |
|
2024
Q2 | $1.22M | Buy |
7,142
+116
| +2% | +$19.9K | 0.96% | 29 |
|
2024
Q1 | $1.28M | Buy |
7,026
+201
| +3% | +$36.6K | 0.96% | 30 |
|
2023
Q4 | $1.06M | Buy |
6,825
+142
| +2% | +$22K | 0.85% | 35 |
|
2023
Q3 | $996K | Sell |
6,683
-15
| -0.2% | -$2.24K | 0.94% | 32 |
|
2023
Q2 | $902K | Buy |
6,698
+46
| +0.7% | +$6.2K | 0.83% | 32 |
|
2023
Q1 | $1.06M | Sell |
6,652
-198
| -3% | -$31.6K | 1.05% | 25 |
|
2022
Q4 | $1.11M | Buy |
+6,850
| New | +$1.11M | 1.15% | 22 |
|